Biweekly occidiofungin for recurring yeast infections
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 65 years old
- You have a confirmed yeast infection with symptoms and visible signs of moderate severity (itching, burning, irritation, redness, or swelling)
- Your vaginal yeast infection has been confirmed with a lab test showing yeast cells
- You weigh between 99 and 242 pounds and have a healthy body mass index (BMI between 18-35)
- You are able to avoid sexual contact from day 1 through day 10 and on days you receive the medication
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a medical-grade honey product (L-Mesitran) to reduce symptoms from recurrent vaginal yeast infections. If you have frequent episodes, the honey treatment may help lower symptom flare-ups compared with usual care.
This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
This study tests a new antifungal medicine (oteseconazole) for women with a moderate to severe yeast infection. It aims to see if the drug works well and is safe.
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
This trial tests a new vaginal cooling device to treat yeast infections. It may help relieve symptoms like itching, burning, or irritation without medication.
Hear when a new Candidiasis, Vulvovaginal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.